Skip to main content

Day: March 12, 2024

Rackspace Technology Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter Revenue of $720 million, down 9% Year-over-Year; 2023 Revenue of $2,957 million, down 5% Year-over-Year Fourth Quarter Private Cloud Revenue of $285 million, down 14% Year-over-Year; 2023 Private Cloud Revenue of $1,210 million, down 12% Year-over-Year Fourth Quarter Public Cloud Revenue of $435 million, down 5% Year-over-Year; 2023 Public Cloud Revenue of $1,747 million up 0.4% Year-over-Year Fourth Quarter Cash Flow From Operating Activities of $72 million; 2023 Cash Flow From Operating Activities of $375 million Since start of 2023, Estimated Net Financial Debt Reduction of over $900 million through Debt Repurchases and Refinancings, Lowering Net Annual Interest Expense by approximately $40 Million, Assuming Full Participation in Public Exchange OfferSAN ANTONIO, March 12, 2024 (GLOBE NEWSWIRE) — Rackspace...

Continue reading

Oportun Reports Fourth Quarter and Full Year 2023 Financial Results

4Q23 Total revenue of $263 million, bringing FY23 to $1.1 billion, up 11% year-over-year Quarterly operating expense down 15% $30 million in additional operating expense reductions announced $200 million February ABS deal completed at 160 bps lower pricing than October transaction Full Year 2024 guidance reflects expectations for markedly improved profitability SAN CARLOS, Calif., March 12, 2024 (GLOBE NEWSWIRE) — Oportun Financial Corporation (Nasdaq: OPRT) (“Oportun”, or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2023. “We executed well during the fourth quarter and met each of our guidance metrics,” said Raul Vazquez, CEO of Oportun. “Our top-line remained resilient and we completed full year 2023 with a record $1.1 billion of total...

Continue reading

Aterian Reports Fourth Quarter & Full Year 2023 Results

Reaffirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2023.  Fourth Quarter 2023 HighlightsFourth quarter 2023 net revenue declined 40.3% to $32.8 million, compared to $54.9 million in the fourth quarter of 2022. Fourth quarter 2023 gross margin increased to 51.0%, compared to 37.1% in the fourth quarter of 2022, primarily reflecting lower liquidation of high cost inventory compared to the prior period. Fourth quarter 2023 contribution margin increased to (0.8%) from (11.5%) in the fourth quarter of 2022, primarily reflecting lower liquidation of high cost inventory compared to the prior period. Fourth quarter 2023 operating loss improved...

Continue reading

Allbirds Reports Fourth Quarter and Full Year 2023 Financial Results; Achieves Q4 Financial Guidance Targets

Allbirds COO Joe Vernachio Appointed CEO as Company Accelerates Strategic Transformation Plan Company Provides 2024 Outlook SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with naturally derived materials to make better footwear and apparel products in a better way, today reported financial results for the fourth quarter ended December 31, 2023. Separately, the Company also announced today that COO Joe Vernachio has been appointed as CEO, effective March 15, 2024. He will oversee all operations and continue advancing Allbirds’ strategic transformation plan. Co-Founder & CEO Joey Zwillinger will remain on the Board of Directors and serve as a special advisor to Allbirds. Fourth Quarter and Full Year 2023 OverviewFourth quarter net revenue decreased 14.5%...

Continue reading

Minim Announces Merger Agreement with e2Companies

Merger to create NASDAQ-listed, comprehensive proprietary products and services company focused on Automated Grid Stability MANCHESTER, N.H., March 12, 2024 (GLOBE NEWSWIRE) — Minim, Inc. (“Minim”) (NASDAQ: MINM) today announced that it has entered into a definitive merger agreement with privately held e2Companies, LLC (“e2Companies”), to combine the companies in an all-stock transaction. The combined company will focus on continuing to drive proprietary solutions for grid modernization. Upon closing, which is currently anticipated in the second quarter of 2024, the combined company is expected to operate under the name e2Companies, Inc., and trade on the Nasdaq Capital Market. “This agreement comes at a pivotal time for e2Companies as we advance the commercialization of our technology platform,” said James Richmond, CEO and President...

Continue reading

AdTheorent Holding Company, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results

Fourth quarter revenue increased 15.2%Exceeded fourth quarter and full-year guidance NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced fourth quarter and full-year 2023 financial results. “AdTheorent completed its second full year as a public company with great momentum, recording more than 15% revenue growth in Q4,” said James Lawson, CEO of AdTheorent. “Our advanced ID-independent machine learning technology and algorithmic audience solutions position us for revenue growth and industry leadership in the post-cookie world, and our team is executing at a high level to take advantage of this significant opportunity.”  Fourth...

Continue reading

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

SOUTH SAN FRANCISCO, Calif., March 12, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today reported recent business progress and financial results for the fourth quarter and full year 2023. “Last year we built the foundation for a critical 2024 by closing a $92 million PIPE from healthcare-dedicated institutional investors and successfully completing our Phase 2a enabling activities for ALG-055009,” stated Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics. “In addition, we presented unprecedented antiviral activity from our ALG-000184 program for chronic hepatitis B (CHB). With these important accomplishments in hand, we are well positioned...

Continue reading

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

• Increased Product Sales to $131 Million in 2023 • Grew Pre-tax Operating Income to $84 Million in 2023 • Declared Today a Special Cash Dividend of $0.60 per Share • Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2023. “In 2023, SIGA had approximately $131 million in product revenues and approximately $84 million of pre-tax operating income,” stated Diem Nguyen, Chief Executive Officer. “These financial results represent a significant increase over the 2022 financial results; product revenues increased 51% over the corresponding 2022 amount, and pre-tax operating income year increased 96% over the corresponding...

Continue reading

Latham Group, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

Full Year 2023 Sales Outperformed the U.S. In-Ground Pool Market in 2023 Driven by Continued Fiberglass Conversion Substantially Reduced Cost Structure During 2023 Full Year Operating Cash Flow of $116 Million Yielded Record Cash Position of $100 Million at Year-End 2024 Guidance Anticipates Continued Ability to Outperform Industry Amid Difficult Market Conditions Fourth Quarter 2023 Highlights:Net sales of $90.9 million, down 15.8% year-over-year Net income of $0.1 million improved from prior year’s net loss of $19.0 million; Net income margin was 0.1% Adjusted EBITDA of $9.9 million, compared to last year’s $4.4 million; Adjusted EBITDA margin was 10.9%Full Year 2023 Highlights:Net sales of $566.5 million, down 18.6% year-over-year Net loss of $2.4 million versus a net loss of $5.7 million in the prior year period; Net loss margin...

Continue reading

Westrock Coffee Company Reports Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

LITTLE ROCK, Ark., March 12, 2024 (GLOBE NEWSWIRE) — Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2023 and provides its outlook on fiscal 2024. Scott T. Ford, CEO and Co-founder stated, “We are pleased to announce our fourth quarter, and full year, 2023 financial results. Last year was a significant transition year for Westrock and we now enter 2024 with a number of critical system migrations and capital equipment upgrades behind us. The entire team worked tirelessly to modernize our legacy manufacturing operations while simultaneously building a new Extract and Ready-to-Drink plant in Conway, Arkansas which is scheduled to deliver its first commercial products to customers next month.” Fourth Quarter HighlightsConsolidated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.